Understanding the burden of post-covid-19 condition.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Prevalence and symptoms of Long Covid-19 in the workplace.Occupational medicine (Oxford, England) · 2025
   Pooled it
2. Excess risks of long COVID symptoms compared with identical symptoms in the general population: A systematic review and meta-analysis of studies with control groups.Journal of global health · 2024
   Pooled it
3. Preventive Intake of a Multiple Micronutrient Supplement during Mild, Acute SARS-CoV-2 Infection to Reduce the Post-Acute COVID-19 Condition: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial.Nutrients · 2024
   Trial
4. Impact of long COVID on diverse Australian populations: a multi-site, longitudinal prospective cohort study protocol.BMJ open · 2026
   Article
5. Long-term healthcare use of COVID-19 cases in 2020: a two-year follow-up in Stockholm, Sweden.Annals of medicine · 2025
   Article
6. Unravelling the complex interplay of age, comorbidities, and multimorbidities in COVID-19 disease progression: Clinical implications and future perspectives.Heliyon · 2024
   Article
7. COVID-19 and persistent symptoms: implications for polycystic ovary syndrome and its management.Frontiers in endocrinology · 2024
   Review
8. Efficacy and safety of acupuncture treatment for fatigue after COVID-19 infection: study protocol for a pilot randomized sham-controlled trial.Frontiers in neurology · 2023
   Article

Corrections and comments

• Comment on
  Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study.2023

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as